麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Florida鈥檚 KidCare
  • LGBTQ+ Youth Crisis Line
  • Device Coverage by Medicare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Florida鈥檚 KidCare
  • LGBTQ+ Youth Crisis Line
  • Device Coverage by Medicare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jun 3 2024

Full Issue

Possible Health Risks Of MDMA PTSD Therapy Highlighted By FDA

The FDA cited flaws in a company's study into the use of MDMA as a treatment for post-traumatic stress disorder. Separately, reports say some drugmakers will cap asthma inhaler costs at $35 a month; and weight loss drugs may boost people's taste buds.

The Food and Drug Administration on Friday raised concerns about the health effects of MDMA as a treatment for post-traumatic stress disorder, citing flaws in a company鈥檚 studies that could pose major obstacles to approval of a treatment anticipated to help people struggling with the condition. The agency said that bias had seeped into the studies because participants and therapists were readily able to figure out who got MDMA versus a placebo. It also flagged 鈥渟ignificant increases鈥 in blood pressure and pulse rates that could 鈥渢rigger cardiovascular events.鈥 (Jacobs and Jewett, 5/31)

Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.聽Following years of public outcry about the high cost of inhalers, the two drugmakers 鈥 along with a third, GlaxoSmithKline 鈥斅 have committed to capping the out-of-pocket cost at $35 a month. GSK鈥檚 cap is expected to take effect by Jan. 1. (Lovelace Jr., Kane and Thompson, 5/31)

On weight loss drugs 鈥

Semaglutide, the active ingredient in popular diabetes and obesity drugs Ozempic and Wegovy, can also tweak people鈥檚 taste buds for the better, preliminary research suggests. Scientists found that women taking semaglutide improved their taste sensitivity, particularly to sweetness. The findings may illuminate another reason why it and similar drugs can so effectively help people lose weight, the authors say. (Cara, 6/2)

While research has looked at the potential mental health impact of taking semaglutide drugs like Ozempic, less has been discussed on how the increase in these drugs are impacting those who aren't taking them.聽Heather Young said she's struggled with weight her entire life, telling CBS News that her teen years and early adulthood were filled with trying "one thing after another only to fail again and again and again and just feel so defeated." (Moniuszko, 6/1)

麻豆女优 Health News: Journalists Talk Cost Of Weight Loss Drugs And Lack Of Obesity Doctors To Manage Their Use

麻豆女优 Health News and California Healthline staff made the rounds on national and local media this week to discuss topical stories. Here鈥檚 a collection of their appearances. (6/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优